Skip to content

LC Pharma Concept

Active
Private limited companyfounded 20197 yrs activeRue des Champs d'en Haut 28, 7160 Chapelle-lez-Herlaimont, BelgiumKBO/BCE: BE 0729.811.271
Summary

The computed 12-month bankruptcy probability of LC Pharma Concept is 1.6% (moderate). The 2025 annual accounts show equity of €4,546 and a net result of -€3,805. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 45% of 11293 sector peers (fiscal year 2025). The company has been active since 2019 and the Belgian State Gazette contains no insolvency or warning signals.

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
€13,961total assets 2025
Equity
€4,546
Loss
-€3,805
Financial health
53 Fair Checked score 2025
Bankruptcy chance 12 m
1.6%
Structure
Accounts on time0 of 1 deed read
Why 53- Liquidity: current ratio 1.36, cash €2, halved- Sector Retail trade (NACE 47)- Founded in 2019+ Size: total assets €13,961Show the evidence

Checked score

Score 2025
53 / 100
Fair
Probability in this band: 1.5% to 4.2%
Better than 20% of its sector peers (NACE 47, micro)
Performance against the sector, not lower risk
Financial strength · tick = 2024
Weak
Solvency 58-39
equity 32.6% of total assets
Liquidity 14-75
short-term debt 67.4% · cash 0.0%
Profitability 0-100
return on assets -27.3%
Bankruptcy probability, 12 months
1.6% Moderate
0%0.5%1.5%4%10%≥ 25%

About 2 in 100 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.7% (39,898 companies)
Last 15 months 08-2025: 2.2%highest value 09-2025: 0.3%▼ -85.5% vs 08-2025 10-2025: 0.3%▼ -10.0% vs 09-2025lowest value 11-2025: 0.3%▲ +1.4% vs 10-2025 12-2025: 0.3%● 0.0% vs 11-2025 01-2026: 0.3%● 0.0% vs 12-2025 02-2026: 0.3%● 0.0% vs 01-2026 03-2026: 0.3%▼ -0.3% vs 02-2026 04-2026: 0.3%▲ +14.5% vs 03-2026 05-2026: 0.3%▼ -1.5% vs 04-2026 06-2026: 0.3%▼ -0.9% vs 05-2026 07-2026: 0.4%▲ +10.8% vs 06-2026 08-2026: 1.6%▲ +358% vs 07-2026 09-2026: 1.6%● 0.0% vs 08-2026 10-2026: 1.6%● 0.0% vs 09-2026
  • Size: total assets €13,961 lowers the probability for this profile
  • Liquidity: current ratio 1.36, cash €2, halved raises the probability
  • Sector Retail trade (NACE 47) raises the probability
  • Founded in 2019 raises the probability for this profile
How it is calculated

The band comes from the bankruptcy probability on a scale of 0 to 100: every 10 points more double the odds of getting through the year without bankruptcy.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Place inside the band: half the bankruptcy probability, half how the company does against its sector peers (NACE 47, micro). Better than this share of them on solvency 48%, liquidity 14%, profitability 6%, growth against the median 12%. That is performance, not lower risk; the band itself always comes from the probability.

Bankruptcy probability: model pd-v3.202610021621, computed on 02-10-2026. The model learns from Belgian bankruptcies and reads the registers, the annual accounts and the gazette.

Ceilings: negative or zero equity, a heavy loss, a special KBO legal situation and a missing filing 59 (two missing 44), an ongoing judicial reorganisation or an ending 24. Financial strength does not count in the score.

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Size: total assets €13,961
In the bankruptcy model this factor lowers the probability for this profile.
NBB · annual accounts
raises risk · Liquidity: current ratio 1.36, cash €2, halved
In the bankruptcy model this factor raises the probability.
NBB · annual accounts
raises risk · Sector Retail trade (NACE 47)
In the bankruptcy model this factor raises the probability.
KBO
raises risk · Founded in 2019
In the bankruptcy model this factor raises the probability for this profile.
KBO
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-07-2026, 0 days ahead of the deadline.
NBB · 7 filings
Deviation from the deadline
2025
on the day
2024
28 d late
2023
5 d late
2022
11 d early
2021
18 d early
2020
2 d late
2019
32 d late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 5 days after the deadline; the sector median for financial year 2024 is on the deadline day, and 47% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 31 July (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Position in the running window
02-10-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2025 · abbreviated…
  2. Weakest financial yearnet -€3,805
  3. Annual accounts filedfiscal year 2024 · full…

Key points

  • Caution: Among the weakest 15% on equitysector median €247,818 · 11,303 companies €4,546 View
  • Total assets 20256 fiscal years filed €13,961 View
  • Active since 2019founded 04-07-2019 7 years View

By topic

Financials

Fiscal year
2025
Total assets
€13,961
Loss
-€3,805
Solvency
32.6%
Total assets▲ 20.8%
Net result
20192025
Go to Financials

Timeline

Events
11
Since
2020
Next accounts
by 31-07-2027
  1. 31-07-2026Annual accounts filed
  2. 31-12-2025Weakest financial year
  3. 28-08-2025Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
04-07-2019
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.